circRNA basic information
circBase ID: hsa_circ_0001947
Name: hsa_circ_DOK7
Synonym: circ_0001947
Host Gene: DOK7
Genomic location(hg19): chrX:147743428-147744289:+
Genomic location(hg38): chrX:148661907-148662768:+
Subcellular localization: not tested
 
 
 
 
 
 
 
Disease basic information
MONDO ID:
0005233
MONDO name: non-small cell lung carcinoma
Disease details: non-small cell lung cancer
Disease DO ID:
3908
Disease MeSH ID:
D002289
Disease NCIt ID:
C2926
Disease ICD11 ID:
-
Disease OMIM ID:
-
Species: Human
Species details: Homo sapiens
Tissue specimen:

NSCLC tissues; adjacent non-tumor tissues

Cell lines:

H1299; A549; H358; H1395; 16HBE

In vivo animal model:

-

circRNA-disease information
Expression pattern:
DN
Associated gene: DOK7
Associated microRNA: miR-661
Biological function: Suppresses NSCLC development by inhibiting cell viability and proliferation, promoting apoptosis, and promoting G0/G1 phase entry (reducing S phase arrest).
Molecular mechanism: Acts as a miRNA sponge (ceRNA) for miR-661, thereby elevating DOK7 expression.
Biological pathway or process:

proliferation (inhibits); apoptosis (promotes); cell cycle (other); ceRNA regulation (promotes)

Detected method:
Q
Validation methods:

RT-qPCR; Transfection; CCK8; Colony Formation Assay; Annexin V/PI Flow Cytometry; Cell Cycle Assay; Luciferase Reporter Assay; Bioinformatics Analysis; Clinical Sample Validation

Clinical significance:

circ_0001947 might be a potential new biomarker for the treatment of NSCLC.

Description:

In NSCLC, circ_0001947 is down-regulated and functions as a tumor suppressor. It sponges miR-661 to relieve repression of DOK7, thereby inhibiting viability/proliferation and promoting apoptosis with cell-cycle effects.

Confidence score:

0.6521

Other information
Title:

Hsa_Circ_0001947/MiR-661/DOK7 Axis Restrains Non-Small Cell Lung Cancer Development.

Journal: Journal of microbiology and biotechnology
Published: 2021
PubMed ID: 34528912
Study type:

combined biological and clinical study

Data availability: -
Code availability: -